Labwire Inc (LBWR): Here are some 2008 projected numbers to...

Reply Private New

Replies (3) Next 10 Prev Next

Send PM Follow Ignore

Followers	24
Posts	3228
Boards Moderated	0
Alias Born	04/23/2006

milo3

Re: None

Sunday, 02/24/2008 5:17:02 PM

Sunday, February 24, 2008 5:17:02 PM

Here are some 2008 projected numbers to consider.
Feel free to offer differences of opinion as this IS a discussion board. : )

A bit of background.
Revenues for 2007 taken from past PRs:
1st Q..$ 1,167,975
2nd Q..$ 1,009,310
3rd Q..$ 1,143,804
4th Q..$ 1,200,000 Not reported yet but 1.2 million estimated
Total $ 4,521,000

Neither Occupational Testing (O T) or the large aero space company - possibly Boeing - revenues are used in calculating the above $ 4.5 million total 2007 revenue figure.

Looking forward into 2008:
In the Dec. 11,'07 PR it was stated that Occupational Testing would add $ 800k to revenues. It also said the purchase amount for (O T) was based on O T's 2006 numbers that had grown 33% in the last year.
Here's where it gets tricky : ) From the Wall Street.Net audio interview of 09/20/07
http://www.wallst.net/audio/audio.asp?ticker=LBWR&id=3881
The aero space co. signing will add upwards of the 60k tests currently being done for Laidlaw. Laidlaw has about 60k-65k that are tested and according to the 10sb recently filed, the Laidlaw contract accounts for $ 2.4 million in yearly revenues. So, IF the aero space co. signing adds more than Laidlaw I'm putting a conservative $ 2.6 million yearly revenue number for it.

IF Labwire's revenue client base in 2007 remains in tact at
$ 4.5 million - as I think it will - and with a small increase of
of growth in Occupational Testing's revenues in '08 yielding a total $ 900k along with the aero space company's '08 contribution of $ 1.6 million - I'm allowing for ramping time the first part of '08 - the total increase in revenues added to the '07 $4.5 million would be $ 7 million.
That's $ 7 million if NO additional revenue streams are added during '08 and I'm looking for 2008 to be a good year for additional new client signings, organic growth from signed 'parent' company subsidiary companies and possibly another acquisition.
milo3